跳至主要内容
临床试验/JPRN-jRCT2080221867
JPRN-jRCT2080221867未知2 期

A Phase II, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of KRP-AB1102 Compared With Placebo for 4- Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

Kyorin Pharmaceutical Co., LTD.0 个研究点目标入组 360 人开始时间: 2012年7月27日最近更新:

试验速览

阶段
2 期
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 40age old 至 ot applicable(—)
性别
All

入选标准

  • Adult male or female COPD patients aged >40, and others.

排除标准

  • - History or current diagnosis of asthma.
  • - Patient hospitalized for an acute COPD exacerbation within 3 months prior to screening visit, and others.

研究者

相似试验

已完成
不适用
Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)-B203 HIV disease resulting in other viral infectionsHIV disease resulting in other viral infectionsB203
PER-017-06COMPREHENSIVE INTERNATIONAL PROGRAM OF RESEARCH ON AIDS - CIPRA,
进行中(未招募)
不适用
A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel Group Study Evaluating the Efficacy, Safety and Tolerability of JTT-130 Administered Twice Daily for 24 Weeks in Treatment-naïve, Metformin Only or Metformin plus Sulfonylurea -treated Obese Type 2 Diabetic Patients - PROMOTEType II Diabetes MellitusMedDRA version: 11.1Level: LLTClassification code 10012601Term: <Manually entered code. Term in E.1.1>
EUCTR2009-011965-10-HUAkros Pharma Inc.460
进行中(未招募)
1 期
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of MEDI3506 in Participants with COPD and Chronic BronchitisModerate to Severe Chronic Obstructive Pulmonary Disease and Chronic BronchitisMedDRA version: 21.1Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2020-000571-20-GBAstraZeneca AB322
进行中(未招募)
不适用
A Randomized Study comparing placebo and ASP3652 in the treatment of chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS)Chronic abacterial Prostatitis/Chronic Pelvic Pain SyndromeMedDRA version: 14.1Level: LLTClassification code 10064189Term: Chronic pelvic pain syndromeSystem Organ Class: 100000004872MedDRA version: 14.1Level: LLTClassification code 10009109Term: Chronic prostatitisSystem Organ Class: 100000004872
EUCTR2010-023775-25-DEAstellas Pharma Europe B.V.350
进行中(未招募)
1 期
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of MEDI3506 in Participants with COPD and Chronic BronchitisModerate to Severe Chronic Obstructive Pulmonary Disease and Chronic BronchitisMedDRA version: 21.1Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2020-000571-20-HUAstraZeneca AB144